Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Interim CAM Commission Report Slated For HHS Secretary Thompson July 16

This article was originally published in The Tan Sheet

Executive Summary

Health & Human Services Secretary Tommy Thompson should receive the White House Commission on Complementary & Alternative Medicine Policy's interim report for review by July 16.

You may also be interested in...



White House Commission To Advocate CAM Coordinating Office

The White House Commission on Complementary & Alternative Medicine Policy's interim report likely will propose the creation of a central office, possibly under the auspices of either HHS or the White House, to coordinate CAM activities and dialogue among federal agencies and the private sector.

White House Commission To Advocate CAM Coordinating Office

The White House Commission on Complementary & Alternative Medicine Policy's interim report likely will propose the creation of a central office, possibly under the auspices of either HHS or the White House, to coordinate CAM activities and dialogue among federal agencies and the private sector.

White House Commission To Advocate CAM Coordinating Office

The White House Commission on Complementary & Alternative Medicine Policy's interim report likely will propose the creation of a central office, possibly under the auspices of either HHS or the White House, to coordinate CAM activities and dialogue among federal agencies and the private sector.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel